| Author | Age (years)/Sex | Arthritis | Involvement except for arthritis | Duration since arthritis development | Biopsy | Treatment | Outcome | Location | Property | Skin lesions appearance | c-PAN diagnosisa | Site | Histologyb |
| Smukler [6] | 66/M | Ankles, knees | Nondestructive | Livedo reticularis and hair loss on the legs | 7 years | 7 years | Skin | Definite | PSL | NR | Synovium | Nonspecific | Intraarticular CS | Steven [7] | 39/M | Right wrist, knee, left hip, ankles | Destructive | Erythematous macular rash on the legs | 4 years | 6 years | Skin | Definite | PSL, SSZ | NR | Flanagan [8] | 50/M | Ankles | Destructive | Erythematous papules, ulcers, and patchy violaceous eruption on the legs | 4 years | 8 years | Skin | Definite | PSL, CPA | PR | Synovium | Nonspecific | 51/M | Ankles | Nondestructive | Erythematous nodules and livedo reticularis on the legs; ulcers on the right leg; mononeuritis in the left leg | Simultaneous | 5 months | Skin | Definite | PSL, AZA | CR | Horai [9] | 60/F | Left ankle, left MTP | Destructive | Ulcers, erythema, and livedo reticularis on the left leg; medium-sized arterial stenosis in the left leg (angiography) | 10 years | 10 years | Skin | Definite | PSL, TAC | PR | Atzmony [10] | 66/F | Left ankle, left midfoot | Destructive | Livedo reticularis, small erythematous nodules, and skin-colored nodules on the legs; ulcers on the left leg; axonal neuropathy on the legs | 4 years | 12 years | Skin | Definite | PSL, MTX | PR | Our case 1 | 74/F | Right knee | Nondestructive | Bilateral digital ulcers | 8 months | 9 months | Synovium | Definite | mPSL, PSL, MTX | CR | Our case 2 | 60/F | Ankles | Nondestructive | Erythematous papules on the forearms and legs | 14 months | 18 months | Skin | Definite | PSL, AZA | CR |
|
|
c-PAN, cutaneous polyarteritis nodosa; PSL, prednisolone; CS, corticosteroid; NR, no remission; SSZ, sulfasalazine; CPA, cyclophosphamide; PR, partial remission; AZA, azathioprine; CR, complete remission; MTP, metatarsophalangeal joint; TAC, tacrolimus; MTX, methotrexate; mPSL, intravenous infusion of methylprednisolone. aAll patients were categorized as c-PAN. bThe pathological evaluation is determined as “definite” when the biopsied tissue showed the presence of necrotizing vasculitis compatible with polyarthritis nodosa.
|